Next Article in Journal
Correction: Diad et al. Novel Amoxicillin-Loaded Sericin Biopolymeric Nanoparticles: Synthesis, Optimization, Antibacterial and Wound Healing Activities. Int. J. Mol. Sci. 2022, 23, 11654
Previous Article in Journal
The Therapeutic Role of NPS-1034 in Pancreatic Ductal Adenocarcinoma as Monotherapy and in Combination with Chemotherapy
Previous Article in Special Issue
Congenital LMNA-Related Muscular Dystrophy in Paediatrics: Cardiac Management in Monozygotic Twins
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 25
Issue 13
10.3390/ijms25136920
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

New Step in Understanding the Pathogenetic Mechanism of Sudden Infant Death Syndrome: Involvement of the Pontine Reticular Gigantocellular Nucleus

by
Anna Maria Lavezzi
1,*,
Riffat Mehboob
2,3,
Francesco Piscioli
4 and
Teresa Pusiol
4
1
“Lino Rossi” Research Center for the Study and Prevention of Unexpected Perinatal Death and SIDS, Department of Biomedical, Surgical and Dental Sciences, University of Milan, 20122 Milano, Italy
2
Lahore Medical Research Center, Lahore 54000, Pakistan
3
National Heart Lung and Blood Institute, National Institute of Health, Bethesda, MD 20892, USA
4
Provincial Health Care Services, Institute of Pathology, Santa Maria del Carmine Hospital, 38068 Rovereto, Italy
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2024, 25(13), 6920; https://doi.org/10.3390/ijms25136920
Submission received: 19 May 2024 / Revised: 18 June 2024 / Accepted: 19 June 2024 / Published: 25 June 2024
(This article belongs to the Special Issue Neuro-Molecular Pathogenetic Mechanisms of Sudden Infant Death Syndrome (SIDS) and Other Infant Neurodevelopmental Disorders)
Browse Figures
Versions Notes

Abstract

:
This study aimed to investigate, for the first time, the potential role of the gigantocellular nucleus, a component of the reticular formation, in the pathogenetic mechanism of Sudden Infant Death Syndrome (SIDS), an event frequently ascribed to failure to arouse from sleep. This research was motivated by previous experimental studies demonstrating the gigantocellular nucleus involvement in regulating the sleep–wake cycle. We analyzed the brains of 48 infants who died suddenly within the first 7 months of life, including 28 SIDS cases and 20 controls. All brains underwent a thorough histological and immunohistochemical examination, focusing specifically on the gigantocellular nucleus. This examination aimed to characterize its developmental cytoarchitecture and tyrosine hydroxylase expression, with particular attention to potential associations with SIDS risk factors. In 68% of SIDS cases, but never in controls, we observed hypoplasia of the pontine portion of the gigantocellular nucleus. Alterations in the catecholaminergic system were present in 61% of SIDS cases but only in 10% of controls. A strong correlation was observed between these findings and maternal smoking in SIDS cases when compared with controls. In conclusion we believe that this study sheds new light on the pathogenetic processes underlying SIDS, particularly in cases associated with maternal smoking during pregnancy.

1. Introduction

Sudden Infant Death Syndrome (SIDS) is the leading cause of death for infants under one year of age, primarily occurring during the awakening phase from sleep. Worldwide SIDS is defined as a death that remains unexplained after a thorough investigation (including the performance of a complete autopsy, examination of the death scene, and review of the clinical history) [1].
Neuropathological research has long focused on investigating developmental alterations in various nuclei and structures of the human brain in SIDS, frequently highlighting the hypoplasia of various structures involved in breathing and sleep–wake control [2,3,4,5,6,7,8,9]. Anomalies of other nuclei not directly involved in these functions (but that widely project to nuclei containing respiratory neurons) have also been detected in this syndrome, such as hypoplasia of the raphe nuclei, which are components of the reticular formation (RF) [10,11]. The RF is a vast network of neurons and nerve fibers distributed along the brainstem midline, subdivided in nuclei without a precise delineation of each other [12,13,14]. These RF nuclei are able to connect and coordinate many brain structures of vital importance by releasing specific neurotransmitters [15,16].
Despite its widespread structure, the RF network has been subdivided into three longitudinal columns: the “median column” that contains the raphe nuclei, which are distributed along the median brainstem region, the “medial column”, grouping the so-called gigantocellular nuclei (due the presence of larger neurons) extended from the medulla oblongata to the pons medially to the median column, and the “lateral column”, mainly composed of parvocellular nuclei (because of the small size of the cells) distributed laterally to the median zone [12,13,14]. Nevertheless, except for the previously mentioned studies concerning the raphe nuclei, no developmental anomalies of other components of the RF have yet been highlighted in SIDS.
In this regard, this paper intends to deepen the investigations into a group of SIDS cases that mainly occurred during sleep in order to evaluate whether, in addition to the brainstem respiratory center, the gigantocellular nucleus (GCn), which is the main component of the medial RF portion, may be involved in these deaths. This research was motivated by previous experimental studies demonstrating the GCn’s involvement in regulating the sleep–wake cycle [17,18,19,20,21,22]. In the context of this study, we also aim to explore the potential role of the GCn in regulating catecholamine synthesis via tyrosine hydroxylase (TH), as imbalances of this enzyme have frequently been documented in SIDS [23,24,25,26]. Furthermore, an additional goal is to investigate whether any developmental alterations in the GCN can be linked to the mother’s medical history.

2. Results

In line with the purpose of this study, the neuropathological examination was mainly focused on the reticular GCn in a series of 28 SIDS and 20 control cases. In brainstem cross sections, this nucleus exhibits a roughly quadrangular structure in outline throughout its extent, which is smaller in the medulla oblongata and more extensive in the caudal pons. Most GCn neurons are large, multipolar, and darkly stained due to the presence of Nissl granules, which appear as irregular aggregates mainly located at the peripheral zone of the cytoplasm. The nucleus often assumes an eccentric position. Smaller cells, always rich in Nissl granules, are often mixed with these neurons.
Although no significant cytoarchitectural or functional anomalies were observed in the medullary portion of the GCn of either the SIDS cases or the controls, morphological and immunohistochemical differences were detected in its upper part (caudal pons). For this reason, only the results relevant to the rostral portion of this nucleus, henceforth indicated with the acronym “pGCn”, where “p” means “pontine”, are included below.

2.1. Morphological Examination of the pGCn

The histological examination of the reticular pGCn was performed on specific serial sections, at the same pontine levels for both SIDS cases and controls, by comparing the results obtained for each SIDS case with those of the age-matched controls. Landmarks of these sections are represented by the presence in each of them of the abducens nucleus, the facial/parafacial complex, and the superior olivary nucleus (Figure 1).
The overall results obtained from the cytoarchitectural analysis of the pGCn led to the following conclusions:
-
The pGCn showed the same widespread distribution of many neurons in all controls and nine SIDS cases (Figure 2A). This finding was considered to be in line with normal nucleus development for infants under one year of age.
-
The pGCn outlook differed for the remaining 19 SIDS cases due to the presence of rare (sometimes extremely rare) neurons. A diagnosis of “pGCn hypoplasia” was made for these cases (Figure 2B).

2.2. TH—Immunohistochemical Examination of the pGCn

Sections immunolabeled for TH showed intensely positive neurons in the pGCn (>80% of neurons) in almost all controls, more specifically in 18 control cases, and in 11 SIDS cases (7 of which with pGCn hypoplasia and 4 with normal pGCn structure) (Figure 3A). In the remaining 17 SIDS cases (12 with pGCn hypoplasia and 5 with normal pGCn structure) and 2 controls, TH immunopositivity was weak or not expressed (<10% of neurons) (Figure 3B).
Overall, SIDS cases showed a significantly higher incidence of histological/immunohistochemical alterations in the pGCn than the age-matched controls. In particular, developmental structural defects (hypoplasia) of the pGCn were observed in 17 SIDS cases, but in no control cases. Similarly, low-to-complete absence of TH expression was found with significantly higher incidence rates in the SIDS group (17 cases) than the control group (2 cases).
Table 1 summarizes both the morphological and immunohistochemical findings described above.

2.3. Correlation of the Results with Risk Factors

2.3.1. Correlations with Cigarette Smoke

Eighteen SIDS mothers and 6 control group mothers were either tobacco or e-cigarette smokers (more than three cigarettes per day) before pregnancy and after their child’s birth.
A strong correlation was observed between pGCn hypoplasia, TH negative/low immunoexpression, and maternal smoking in SIDS cases compared with the control cohort (p < 0.01). Overall, 15 of the 19 SIDS cases with pGCn hypoplasia were born to one of the 18 mothers of SIDS infants who smoked. No or mild TH immunostaining was observed in a few of the neurons of 11 of these cases. The remaining three SIDS cases born to smoking mothers showed weak TH expression in pGCn neurons with a normal structure.
Regarding the control group, TH expression deficiency was observed in two of the six cases born to smoking mothers, while no alterations were detected in the other four cases (Table 2).

2.3.2. Correlations with Alcohol/Drug Misuse and Environmental Pollutants

No correlation was assessed regarding the intake of alcohol or drugs, as all mothers denied having taken these substances. Differences, although not significant, were detected between SIDS cases and controls regarding the exposure to airborne toxicants (such as particulate matter, pesticides, polycyclic aromatic hydrocarbons, toxic metals, etc.). Based on our investigations, only five mothers of the SIDS group (18%) and two mothers of the control group (10%) spent their pregnancy and the postpartum period in agricultural areas where pesticides are often used, or near industries that use toxic materials.

3. Discussion

The focus of this study was on one of the components of the reticular formation, namely the gigantocellular nucleus (GCn), with the aim of broadening our knowledge on the pontine tract (pGCn) due to its involvement in the control of sleep–wake cycles, as highlighted in experimental studies. In particular, Goutagny et al. [18] proved that bilateral lesions of the pontine GC tegmental field in cats resulted in the complete elimination of paradoxical sleep (REM phase), a recurring part of the sleep–wake cycle. Similarly, Siegel et al. [19] demonstrated that pGC field neurons are able to modulate sleeping and waking activity. The study of Sirieix et al. [21] explained how the pGCn interacts with other brainstem nuclei, such as the locus coeruleus and raphe nuclei, to influence the sleep–wake cycle by initiating and maintaining wakefulness and helping to regulate rapid-eye-movement (REM) sleep. Consequently, damage or dysfunction of the pGCn may result in sleep disorders.
In the context of this study, in addition to the morphological examination of the GCn with specific histological techniques, we applied TH immunohistochemistry, a valuable tool in neuropathology, as it specifically detects the presence of tyrosine hydroxylase, a key enzyme responsible for the synthesis of catecholamines (adrenaline, noradrenaline, and dopamine) in neurons [27,28]. A decrease in TH immunoreactivity is a common feature of neurodegenerative diseases like Parkinson’s disease, in which there is a reduction in dopamine production [29,30]. As there are currently no studies demonstrating how p GCn can affect SIDS, a syndrome that mostly occurs during sleep, especially upon awakening, we aimed to analyze the TH expression in the GCn in a series of babies who died suddenly, aligning with the aforementioned study by Gao et al. [17]. Notably, these authors identified a subset of neurons within the GCn that can promote arousal from sleep by activating the cholinergic, noradrenergic, and glutamatergic arousal pathways.
The results of our study fulfilled our expectations as they highlighted a significantly higher incidence of both structural and functional neuronal abnormalities in the pontine portion of the GCn in SIDS cases than in the age-matched controls. More specifically, neuronal deficiency (hypoplasia, even severe) of the pGCn was found in a high percentage of SIDS cases (68%), contrary to what was observed in all control cases, in which the development of the pGCn constantly showed a normal structure. Similarly, the immunohistochemical expression of TH was low or absent in 61% of SIDS cases (12 of which with GCn hypoplasia), while this was observed in only 10% of control subjects. Normally, the TH level in the catecholaminergic neurons, and hence in the GCn, is highest during waking and decreases with oscillations during sleep [31]. Increases in TH proteins and mRNA have been reported to occur in normal subjects in response to stress conditions [32]. We therefore believe that, in most SIDS, given the low-to-complete absence of TH expression in pGCn neurons, this functional response does not occur by impairing the sleep–wake cycle.

3.1. Genetics of the TH Enzyme

In humans, the TH enzyme is encoded by the TH gene, which contains a tetrameric short tandem repeat in intron 1 (TH01) [33,34]. Mutations or variants (polymorphisms, rare variants) of the TH gene can result in the reduced activity of TH enzymes, thus affecting normal nervous system function.
A polymorphism of the TH gene, namely allele 9.3, has been investigated in several SIDS studies [35,36,37]. This genetic variant causes defects in the synthesis and/or storage of catecholamines, especially of noradrenaline, which is essential for regulating breathing and arousal. Our finding of poor or absent TH expression observed during the immunohistochemical examination of the pGCn, especially in SIDS, suggests the existence of this polymorphism. Of course, we intend to confirm our assumption by analyzing the TH genetic features of all the cases involved in our study as soon as possible.
The significant association observed between abnormal findings (namely hypoplasia and TH-negative/low immunoexpression) and maternal smoking, particularly within the SIDS group, is noteworthy.
Our observation of nicotine exposure in utero causing defects in TH expression and cytoarchitecture specifically in the pGCn, but not in other brainstem centers, differs from previous studies showing a significant correlation between maternal smoking during pregnancy and alterations in various brain regions [38,39,40,41,42]. This finding suggests biological variability in response to prenatal smoke exposure, impacting the development of specific structures in different brain areas.
The negative effects of maternal smoking, especially during pregnancy, on the newborn have been widely documented by numerous studies worldwide. Among these, low birth weight (LBW) and small size for gestational age (SGA) are well known [43,44,45]. Furthermore, a large number of epidemiologic studies have shown a very high relationship between maternal smoking and SIDS [46,47,48,49,50].
Specific morphological and functional developmental alterations in the nervous system, such as serotonergic alterations, nicotinic receptor alterations, grow factor expression abnormalities, hypoplasia of brainstem nuclei, and alterations in the nerve centers involved in regulating cardiorespiratory function, have been found to be related to prenatal nicotine exposure [38,39,40,41,42,51,52,53]. When a mother smokes during pregnancy, the nicotine is rapidly absorbed by the lungs and enters the maternal bloodstream. From here, above all, the CO, a gaseous combustion product of nicotine, crosses the placental barrier and passes into the fetal bloodstream forming carboxyhemoglobin, a complex that creates hypoxic conditions in the tissues as it is unable to release oxygen.
Furthermore, nicotine is one of the few lipid-soluble substances that can readily cross the blood–brain barrier. This allows it direct access to fetal brain parenchyma, where it can interfere with the expression of genes that control nervous system development.

3.2. Limitations of the Study

The study was limited by the difficulty we encountered in ensuring consistent and optimal fixation times for the brain samples in both the SIDS and control groups, as we are aware that prolonged fixation can affect immunohistochemical TH expression. Another limitation consists of the disparity between the number of SIDS cases and that of control cases (n = 28 SIDS vs. n = 20 controls). However, a smaller size of the control group is common in the literature in studies performed on SIDS, and this is indicative of the general difficulty in finding infants who died in the first months of life from well-defined causes.

3.3. Conclusions

As a concluding remark, our findings suggest that pGCn developmental defects, encompassing both structural and functional abnormalities, alone or in association with other brain abnormalities, may contribute to impaired motor activation during awakening, a hallmark of SIDS. This effect might be particularly pronounced when combined with hypoxia caused by maternal cigarette smoking during pregnancy. We believe this study has the potential to reveal novel insights into the pathological mechanisms underlying SIDS, especially in cases with established risk factors like maternal smoking.

4. Materials and Methods

4.1. Study Subjects

This study included a cohort of SIDS cases and a control group, comprising a total of 48 infants.
  • The SIDS group was composed of 28 cases (12 females and 16 males, aged from 1 to 7 postnatal months). SIDS was diagnosed because the routine post-mortem examination was unable to establish any cause of death. Therefore, an in-depth analysis of the nervous system was carried out with particular investigation of the brainstem, where main nervous centers of vital importance are located, in accordance with the directives of Italian law n.31/2006 “Regulations for Diagnostic Post Mortem Investigation in Victims of Sudden Infant Death Syndrome (SIDS) and Unexpected Fetal Death” [54]. These 28 cases were selected from a large number of SIDS victims in which no developmental abnormalities in the main vital nervous centers were detected at the thorough neuropathological examination.
  • The control group was composed of 20 suddenly deceased subjects (8 females and 12 males, aged from 2 to 7 postnatal months) for whom a complete autopsy and clinical history analysis established a precise cause of death. Specific diagnoses included the following: congenital heart disease (n = 6); respiratory infection (n = 6); disorders related to prematurity (n = 2); traumatic incident (n = 2); congenital malformations (n = 2); medium-chain acyl-coenzyme A dehydrogenase (MCAD) deficit (n = 1); sepsis (n = 1).
For each case, a complete clinical history, including all available data regarding the pregnancy, birth, and the environmental situation in which the death occurred, was collected.
All the cases of this study came from Italian regions (mostly from Trentino), based on the directives of the aforementioned Italian law.

4.2. Risk Factor Information

Information on the main potential risk factors (above all, maternal cigarette smoking, alcohol and drug misuse before and during pregnancy, and environmental risks present in the area where the pregnant mothers and their babies lived) were collected and analyzed. Particular emphasis was given to maternal cigarette (including e-cigarette) smoking.
Based on their statements, 18 of the 28 SIDS mothers (64%) were active smokers (with consumption of more than 3 cigarettes/day) before, during, and after pregnancy until the child’s death. The remaining 10 mothers (36%) denied having smoked in the past. Little information was available on the smoking habits of the victims’ fathers or of other people living in the household.
Six of the twenty control mothers (30%) admitted to smoking more than 3 cigarettes a day before their pregnancy. The remaining 14 mothers (70%) denied the habit of smoking.
No relevant information was obtained regarding maternal alcohol and/or drug misuse. Information on the presence of pollutants in the environment where the mother lived until her child’s death was obtained in a few cases (5 SIDS cases and 2 controls).

4.3. Neuropathological Examination

The methods used for the in-depth examination of the nervous system are described in our previous articles [8,9,55].
The focus of this study was on the GCn. This nucleus extends from the upper third of the medulla oblongata—where it can be found dorsal to the inferior olivary nucleus and lateral to the raphe obscurus nucleus—to the caudal portion of the pons, where it reaches its maximum size.
The portion of the brainstem where the GCn is located was first cut into transverse sequential slices orthogonally to the brainstem axis. Then, 5–6 μm sections were obtained from each of them. Two of these were stained for the histological examination of the GCn cytoarchitecture by using, in addition to the routine hematoxylin–eosin staining, the more specific Klüver–Barrera approach, while immunohistochemical assays were applied on other sections in order to determine the neuronal expression of tyrosine hydroxylase (TH), a marker of catecholaminergic neurons [27,28], in the GCn.

TH (Tyrosine-Hydroxylase) Immunohistochemistry

The selected sections were rinsed three times in Trizma-buffered saline (TBS) 0.1 M, pH 7.4, and then incubated at 4 °C in a 1/500 dilution of primary rabbit antiserum to TH (Chemicon, Temecula, CA, USA) for 48 h. The dilutions were prepared with a solution of 1% normal goat serum (NGS) in 0.05 TBS. This was followed by a 2.5 h incubation in a 1/200 dilution of biotinylated goat anti-mouse immunoglobulin G (IgG) (Vector Laboratories, Burlingame, CA, USA) in 1% NGS in Tris saline. The sections were then incubated for 2 h with the avidin–biotin complex (Vector Laboratories) diluted 1/100 with 1% NGS in Tris saline. Between each incubation, the sections were rinsed three times with 1% NGS in Tris saline. The sections were then treated for 6 min with a 0.05% solution of 3,3′diamino-benzidine and 0.01% hydrogen peroxide, rinsed in phosphate buffer, mounted on gel-coated slides, cleared in xylene, and coverslipped with Depex mounting medium.
All of the observations were acquired with a Nikon Eclipse E800 light microscope (Nikon Corporation, Tokyo, Japan) and the images of interest were taken using a Nikon Coolpix 8400 digital camera (Nikon Corporation, Tokyo, Japan) attached to the microscope.

4.4. Statistical Methods

All findings were analyzed by two blinded independent pathologists. The evaluations of each observer regarding the various parameters were reported separately in a case report table. After the mean values were calculated, they were compared using the K Index (KI) in order to determine interobserver reproducibility. The Landis and Koch [56] method was then used to interpret the K values (0 to 0.2 = slight agreement; 0.21 to 0.40 = fair agreement; 0.41 to 0.60 = moderate agreement; 0.61 to 0.80 = strong or substantial agreement; 0.81 to 0.99 = very strong or almost perfect agreement; 1.0 = perfect agreement). A very satisfactory KI value (0.89) was obtained in this study. The statistical significance of the direct comparisons between groups was determined using the analysis of variance. The calculations were performed with SPSS software (statistical package for social science, version 11.0; SPSS Inc., Chicago, IL, USA). Differences were considered statistically significant if the p values were <0.05.

4.5. Ethics Approval and Consent

Institutional review board approval was not required for this study since it complies with the requirements of the aforementioned Italian law. Regardless, parents of all SIDS cases and all controls provided written informed consent to both autopsy and related research.

Author Contributions

A.M.L.: Conceptualization, Investigation, Writing; R.M.: Investigation, Review and Editing; F.P. and T.P.: Autopsy Activity and Case History Collection, Methodology. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Informed consent was obtained from all parents of subjects involved in the study.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Krous, H.F.; Beckwith, J.B.; Byard, R.W.; Rognum, T.O.; Bajanowski, T.; Corey, T.; Cutz, E.; Hanzlick, R.; Keens, T.G.; Mitchell, E.A. Sudden infant death syndrome and unclassified sudden infant deaths: A definitional and diagnostic approach. Pediatrics 2004, 114, 234–238. [Google Scholar] [CrossRef] [PubMed]
  2. Bright, F.M.; Vink, R.; Byard, R.W. Neuropathological Developments in Sudden Infant Death Syndrome. Pediatr. Dev. Pathol. 2018, 21, 515–521. [Google Scholar] [CrossRef] [PubMed]
  3. Kinney, H.C. Brainstem mechanisms underlying the sudden infant death syndrome: Evidence from human pathologic studies. Dev. Psychobiol. 2009, 51, 223–233. [Google Scholar] [CrossRef] [PubMed]
  4. Machaalani, R.; Waters, K.A. Neurochemical abnormalities in the brainstem of the Sudden Infant Death Syndrome (SIDS). Paediatr. Respir. Rev. 2014, 15, 293–300. [Google Scholar] [CrossRef] [PubMed]
  5. Naeye, R.L. Brain-stem and adrenal abnormalities in the sudden-infant-death syndrome. Am. J. Clin. Pathol. 1976, 66, 526–530. [Google Scholar] [CrossRef] [PubMed]
  6. Squier, W. Neuropathology of SIDS. In Autopsy Findings; Section 5, Chapter 15; Cohen, M.C., Scheimberg, I.B., Eds.; Cambridge University Press: Cambridge, UK, 2019; pp. 95–99. [Google Scholar]
  7. Blackburn, J.; Chapur, V.F.; Stephens, J.A.; Zhao, J.; Shepler, A.; Pierson, C.R.; Otero, J.J. Revisiting the Neuropathology of Sudden Infant Death Syndrome (SIDS). Front. Neurol. 2020, 11, 594550. [Google Scholar] [CrossRef] [PubMed]
  8. Lavezzi, A.M.; Ferrero, S.; Paradiso, B.; Chamitava, L.; Piscioli, F.; Pusiol, T. Neuropathology of Early Sudden Infant Death Syndrome-Hypoplasia of the Pontine Kolliker-Fuse Nucleus: A Possible Marker of Unexpected Collapse during Skin-to-Skin. Care. Am. J. Perinatol. 2019, 36, 460–471. [Google Scholar] [CrossRef] [PubMed]
  9. Lavezzi, A.M.; Poloniato, A.; Rovelli, R.; Lorioli, L.; Iasi, G.A.; Pusiol, T.; Barera, G.; Ferrero, S. Massive Amniotic Fluid Aspiration in a Case of Sudden Neonatal Death with Severe Hypoplasia of the Retrotrapezoid/Parafacial Respiratory Group. Front. Pediatr. 2019, 7, 116. [Google Scholar] [CrossRef] [PubMed]
  10. Lavezzi, A.M.; Casale, V.; Oneda, R.; Weese-Mayer, D.E.; Matturri, L. Sudden infant death syndrome and sudden intrauterine unexplained death: Correlation between hypoplasia of raphé nuclei and serotonin transporter gene promoter polymorphism. Pediatr. Res. 2009, 66, 22–27. [Google Scholar] [CrossRef]
  11. Cerpa, V.J.; Aylwin, M.D.L.L.O.; Beltrán-Castillo, S.; Bravo, E.U.; Llona, I.R.; Richerson, G.B.; Eugenín, J.L. The Alteration of Neonatal Raphe Neurons by Prenatal-Perinatal Nicotine. Meaning for Sudden Infant Death Syndrome. Am. J.Respir. Cell. Mol. Biol. 2015, 53, 489–499. [Google Scholar] [CrossRef]
  12. Mangold, S.A.; M Das, J. Neuroanatomy, Reticular Formation. In StatPearls [Internet]; StatPearls Publishing: Treasure Island, FL, USA, 2023. Available online: https://www.ncbi.nlm.nih.gov/books/NBK556102/ (accessed on 25 July 2022).
  13. Augustine, J.R. The Reticular Formation. In Human Neuroanatomy, 2nd ed.; John Wiley & Sons: Hoboken, NJ, USA, 2016; Chapter 9; pp. 141–153. ISBN 978-1119073994. [Google Scholar]
  14. Horn, A.K. The reticular formation. Pro.Brain Res. 2006, 151, 127–155. [Google Scholar]
  15. Bucci, D.; Buscet, C.L.; Calierno, M.T.; Di Piet, P.; Madonna, M.; Biagioni, F.; Ryskalin, L.; Limanaqi, F.; Nicoletti, F.; Fornai, F. Systematic Morphometry of Catecholamine Nuclei in the Brainstem. Front. Neuroanat. 2017, 11, 98. [Google Scholar] [CrossRef] [PubMed]
  16. Kinney, H.C.; Hayne, L. The Serotonin Brainstem Hypothesis for the Sudden Infant Death Syndrome. J. Neuropathol. Exp. Neurol. 2019, 78, 765–779. [Google Scholar] [CrossRef] [PubMed]
  17. Gao, S.; Proekt, A.; Renier, N.; Calderon, D.P.; Pfaff, D.W. Activating an anterior nucleus gigantocellularis subpopulation triggers emergence from pharmacologically-induced coma in rodents. Nat. Commun. 2019, 10, 2897. [Google Scholar] [CrossRef] [PubMed]
  18. Goutagny, R.; Luppi, P.H.; Salvert, D.; Lapray, D.; Gervasoni, D.; Fort, P. Role of the dorsal paragigantocellular reticular nucleus in paradoxical (rapid eye movement) sleep generatioKobayashin: A combined electrophysiological and anatomical study in the rat. Neuroscience 2008, 152, 849–857. [Google Scholar] [CrossRef] [PubMed]
  19. Siegel, J.M.; McGinty, D.J.; Breedlove, S.M. Sleep and waking activity of pontine gigantocellular field neurons. Exp. Neurol. 1977, 56, 553–573. [Google Scholar] [CrossRef] [PubMed]
  20. Jones, B.E. Elimination of paradoxical sleep by lesions of the pontine gigantocellular tegmental field in the cat. Neurosci. Lett. 1979, 13, 285–293. [Google Scholar] [CrossRef] [PubMed]
  21. Sirieix, C.; Gervasoni, D.; Luppi, P.H.; Léger, L. Role of the Lateral Paragigantocellular Nucleus in the Network of Paradoxical (REM) Sleep: An Electrophysiological and Anatomical Study in the Rat. PLoS ONE 2012, 7, e28724. [Google Scholar] [CrossRef]
  22. Webster, H.H.; Friedman, L.; Jones, B.E. Modification of paradoxical sleep following transections of the reticular formation at the pontomedullary junction. Sleep 1986, 9, 1–23. [Google Scholar] [CrossRef]
  23. Obernai, T.; Yasuhara, M.; Nakamur, T.; Takashima, S. Catecholamine neurons alteration in the brainstem of sudden infant death syndrome victims. Pediatrics 1998, 101, 285–288. [Google Scholar]
  24. Ozawa, Y.; Obonai, T.; Itoh, M.; Aoki, Y.; Funayama, M.; Takashima, S. Catecholaminergic neurons in the diencephalon and basal ganglia of SIDS. Pediatr. Neurol. 1999, 21, 471–475. [Google Scholar] [CrossRef]
  25. Jobe, A.H. Catecholamines on SIDS. J. Pediatr. 2008, 153, A1. [Google Scholar] [CrossRef] [PubMed]
  26. Lavezzi, A.M. Altered Development of Mesencephalic Dopaminergic Neurons in SIDS: New Insights into Understanding Sudden Infant Death Pathogenesis. Biomedicines 2021, 9, 1534. [Google Scholar] [CrossRef]
  27. Nagatsu, T.; Levitt, M.; Udenfried, S. Tyrosine Hydroxylase. The initial step in norepinephrine biosynthesis. J. Biol. Chem. 1964, 239, 2910–2917. [Google Scholar] [CrossRef]
  28. Daubner, S.C.; Le, T.; Wang, S. Tyrosine hydroxylase and regulation of dopamine synthesis. Arch. Biochem. Biophys. 2011, 508, 1–12. [Google Scholar] [CrossRef] [PubMed]
  29. Haavik, J.; Tosk, K. Tyrosine hydroxylase and Parkinson’s disease. Mol. Neurobiol. 1998, 16, 285–309. [Google Scholar] [CrossRef]
  30. Zhu, Y.; Zhang, J.; Zeng, Y. Overview of tyrosine hydroxylase in Parkinson’s disease. CNS Neurol. Disord. Drug Targets 2012, 11, 350–358. [Google Scholar] [CrossRef] [PubMed]
  31. Aston-Jones, G.; Bloom, F.E. Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle. J. Neurosci. 1981, 1, 876–886. [Google Scholar] [CrossRef] [PubMed]
  32. Basheer, R.; Magner, M.; McCarley, R.W.; Shiromani, P.J. REM sleep deprivation increases the levels of tyrosine hydroxylase and norepinephrine transporter mRNA in the locus coeruleus. Brain Res. Mol. Brain Res. 1998, 57, 235–240. [Google Scholar] [CrossRef]
  33. Klintschar, M.; Immel, U.D.; Stiller, D.; Kleiber, M. TH01, a tetrameric short tandem repeat locus in the tyrosine hydroxylase gene: Association with myocardial hypertrophy and death from myocardial infarction? Dis. Markers. 2005, 21, 9–13. [Google Scholar] [CrossRef]
  34. Puers, C.; Hammond, H.A.; Jin, L.; Caskey, C.T.; Schumm, J.W. Identification of repeat sequence heterogeneity at the polymorphic short tandem repeat locus HUMTH01[AATG]n and reassignment of alleles in population analysis by using a locus-specific allelic ladder. Am. J. Hum. Genet. 1993, 53, 953–958. [Google Scholar] [PubMed]
  35. Courts, C.; Madea, B. Significant association of TH01 allele 9.3 and SIDS. J. Forensic. Sci. 2011, 56, 415–417. [Google Scholar] [CrossRef] [PubMed]
  36. Studer, J.; Bartsch, C.; Haas, C. Tyrosine hydroxylase TH01 9.3 allele in the occurrence of sudden infant death syndrome in Swiss Caucasians. J. Forensic. Sci. 2014, 59, 1650–1653. [Google Scholar] [CrossRef] [PubMed]
  37. Klintschar, M.; Reichenpfader, B.; Saternus, K.S. A functional polymorphism in the tyrosine hydroxylase gene indicates a role of noradrenalinergic signaling in sudden infant death syndrome. J. Pediatr. 2008, 153, 190–193. [Google Scholar] [CrossRef] [PubMed]
  38. Lavezzi, A.M.; Mehboob, R.; Alfonsi, G.; Ferrero, S. Substantia Nigra Abnormalities Provide New Insight on the Neural Mechanisms Underlying the Sleep-Arousal Phase Dysfunctions in Sudden Infant Death Syndrome. ASN Neuro 2020, 12, 1759091420962695. [Google Scholar] [CrossRef] [PubMed]
  39. Wells, A.C.; Lotfipour, S. Prenatal nicotine exposure during pregnancy results in adverse neurodevelopmental alterations and neurobehavioral deficits. Adv. Drug Alcohol Res. 2023, 3, 11628. [Google Scholar] [CrossRef] [PubMed]
  40. Lavezzi, A.M.; Matturri, L.; Del Corno, G.; Johanson, C.E. Vulnerability of fourth ventricle choroid plexus in sudden unexplained fetal and infant death syndromes related to smoking mothers. Int. J. Dev. Neurosci. 2013, 31, 319–327. [Google Scholar] [CrossRef] [PubMed]
  41. Lavezzi, A.M.; Mecchia, D.; Matturri, L. Neuropathology of the area postrema in sudden intrauterine and infant death syndromes related to tobacco smoke exposure. Auton Neurosci. 2012, 166, 29–34. [Google Scholar] [CrossRef] [PubMed]
  42. Bublitz, M.H.; Stroud, L.R. Maternal smoking during pregnancy and offspring brain structure and function: Review and agenda for future research. Nicotine Tob. Res. 2012, 14, 388–397. [Google Scholar] [CrossRef]
  43. Rumrich, I.; Vähäkangas, K.; Viluksela, M.; Gissler, M.; de Ruyter, H.; Hänninen, O. Effects of maternal smoking on body size and proportions at birth: A register-based cohort study of 1.4 million births. BMJ. Open 2020, 10, e033465. [Google Scholar] [CrossRef]
  44. Magee, B.D.; Hattis, D.; Kivel, N.M. Role of smoking in low birth weight. J. Reprod. Med. 2004, 49, 23–27. [Google Scholar] [PubMed]
  45. Butler, N.R.; Goldstein, H.; Ross, E.M. Cigarette smoking in pregnancy: Its influence on birth weight and perinatal mortality. Br. Med. J. 1972, 2, 127–130. [Google Scholar] [CrossRef] [PubMed]
  46. Mitchell, E.A.; Ford, R.P.; Stewart, A.W.; Taylor, B.J.; Becrof, D.M.; Thompson, J.M.; Scragg, R.; Hassall, I.B.; Barry, D.M.; Allen, E.M.; et al. Smoking and the sudden infant death syndrome. Pediatrics 1993, 91, 893–896. [Google Scholar] [CrossRef] [PubMed]
  47. Schoendorf, K.C.; Kiely, J.L. Relationship of sudden infant death syndrome to maternal smoking during and after pregnancy. Pediatrics 1992, 90, 905–908. [Google Scholar] [CrossRef] [PubMed]
  48. Slotkin, T.A.; Lappi, S.E.; McCook, E.C.; Lorber, B.A.; Seidler, F.J. Loss of neonatal hypoxia tolerance after prenatal nicotine exposure: Implications for sudden infant death syndrome. Brain Res. Bull. 1995, 38, 69–75. [Google Scholar] [CrossRef] [PubMed]
  49. Anderson, T.M.; Lavista Ferres, J.M.; Ren, S.Y.; Moon, R.Y.; Goldstein, R.D.; Ramirez, J.M.; Mitchell, E.A. Maternal smoking before and during pregnancy and the risk of Sudden Unexpected Infant Death. Pediatrics 2019, 143, e20183325. [Google Scholar] [CrossRef] [PubMed]
  50. Bednarczuk, N.; Milner, A.; Greenough, A. The Role of Maternal Smoking in Sudden Fetal and Infant Death Pathogenesis. Front. Neurol. 2020, 11, 586068. [Google Scholar] [CrossRef] [PubMed]
  51. Kinney, H.C.; Richerson, G.B.; Dymecki, S.M.; Darnall, R.A.; Nattie, E.E. The brainstem and serotonin in the sudden infant death syndrome. Annu. Rev. Pathol. 2009, 4, 517–550. [Google Scholar] [CrossRef] [PubMed]
  52. Lavezzi, A.M.; Ferrero, S.; Roncati, L.; Piscioli, F.; Matturri, L.; Pusiol, T. Nicotinic Receptor Abnormalities in the Cerebellar Cortex of Sudden Unexplained Fetal and Infant Death Victims-Possible Correlation With Maternal Smoking. ASN Neuro 2017, 9, 1759091417720582. [Google Scholar] [CrossRef]
  53. Lavezzi, A.M. Toxic Effect of Cigarette Smoke on Brainstem Nicotinic Receptor Expression: Primary Cause of Sudden Unexplained Perinatal Death. Toxics 2018, 6, 63. [Google Scholar] [CrossRef]
  54. Constitution of the Italian Republic Law n° 31. Regulations for Diagnostic Postmortem Investigation in Victims of Sudden Infant Death Syndrome (SIDS) and Unexpected Fetal Death, Official Gazette of the Italian Republic, General Series, 34. 2006, p. 4. Available online: http://users.unimi.it/centrolinorossi/files/gazz_ufficiale.pdf (accessed on 29 May 2015).
  55. Lavezzi, A.M.; Ferrero, S.; Roncati, L.; Matturri, L.; Pusiol, T. Impaired orexin receptor expression in the Kölliker-Fuse nucleus in sudden infant death syndrome: Possible involvement of this nucleus in arousal pathophysiology. Neurol. Res. 2016, 38, 706–716. [Google Scholar] [CrossRef] [PubMed]
  56. Landis, R.J.; Koch, G.G. The measurement of observer agreement for categorical data. Biometrics 1977, 33, 159–174. [Google Scholar] [CrossRef]
Ijms 25 06920 g001
Figure 1. Transversal section of the caudal pons at the level where the abducens nucleus, the facial/parafacial complex, and the superior olivary nucleus are visible. The red circles indicate the location of the pontine gigantocellular nucleus. Klüver–Barrera staining. Scale bar 1500 μm. Abne = abducens nerve; abnu = abducens nucleus; fn = facial nerve; f/pfc = facial/parafacial complex; fv = fourth ventricle; icp = inferior cerebellar peduncle; mcp = middle cerebellar peduncle; ml = medial lemniscus; mrn = magnus raphe nucleus; pcf = pontocerebellar fibers; son = superior olivary nucleus. Top right: Brainstem diagram with indication (red dashed line) of the pontine level of the section represented here.
Figure 1. Transversal section of the caudal pons at the level where the abducens nucleus, the facial/parafacial complex, and the superior olivary nucleus are visible. The red circles indicate the location of the pontine gigantocellular nucleus. Klüver–Barrera staining. Scale bar 1500 μm. Abne = abducens nerve; abnu = abducens nucleus; fn = facial nerve; f/pfc = facial/parafacial complex; fv = fourth ventricle; icp = inferior cerebellar peduncle; mcp = middle cerebellar peduncle; ml = medial lemniscus; mrn = magnus raphe nucleus; pcf = pontocerebellar fibers; son = superior olivary nucleus. Top right: Brainstem diagram with indication (red dashed line) of the pontine level of the section represented here.
Ijms 25 06920 g001
Ijms 25 06920 g002
Figure 2. (A) pGCn in histological sections of caudal pons. (A) Normal structure of the pGC (control case—male, 4 months); (B) hypoplasia of pGCn with low number of cells in a SIDS case (male, 4 months). Klüver–Barrera staining. Scale bar 70 μm.
Figure 2. (A) pGCn in histological sections of caudal pons. (A) Normal structure of the pGC (control case—male, 4 months); (B) hypoplasia of pGCn with low number of cells in a SIDS case (male, 4 months). Klüver–Barrera staining. Scale bar 70 μm.
Ijms 25 06920 g002
Ijms 25 06920 g003
Figure 3. Photomicrographs showing (A) tyrosine hydroxylase-positive immunolabeled cells in the pGCn of a control case (female, 3 months) and (B) tyrosine hydroxylase-negative cells in a SIDS case with a normal GCn structure (female, 3 months). TH immunohistochemistry. Scale bar, 100 μm.
Figure 3. Photomicrographs showing (A) tyrosine hydroxylase-positive immunolabeled cells in the pGCn of a control case (female, 3 months) and (B) tyrosine hydroxylase-negative cells in a SIDS case with a normal GCn structure (female, 3 months). TH immunohistochemistry. Scale bar, 100 μm.
Ijms 25 06920 g003
Table 1. pGCn morphological and immunohistochemical results of SIDS and control cases.
Table 1. pGCn morphological and immunohistochemical results of SIDS and control cases.
SIDS
n.28		Controls
n.20
pGCn
cytoarchitecture		Normal9 (32%) 20 (100%)
Hypoplasia19 (68%)0 (0%)
pGCn
TH immunoexpression		Normal11 * (39%) 18 (90%)
Weak/negative17 ** (61%) 2 (10%)
Categorical data are expressed as number of cases and percentages. * Four of these cases with normal pGCn structure and seven with pGCn hypoplasia. ** Five of these with pGCn normal structure and twelve with pGCn hypoplasia. Statistical significance of SIDS vs. control group values p < 0.01. pGCn: pontine gigantocellular nucleus; TH: tyrosine hydroxylase.
Table 2. Correlation between maternal smoking and pGCn morphological/immunohistochemical results in SIDS and controls.
Table 2. Correlation between maternal smoking and pGCn morphological/immunohistochemical results in SIDS and controls.
SIDSControls
Maternal smokingYesNoYesNo
18 (64%)10 (36%)6 (30%)14 (70%)
Findings
Normal pGCn cytoarchitecture + normal TH expression010414
pGCn hypoplasia *15 000
Normal pGCn cytoarchitecture and TH weak/negative expression3 020
Categorical data are expressed as number of cases. * Twelve of these cases with weak TH expression. Statistical significance of SIDS vs. control group values in relation to maternal smoking p < 0.01 pGCn: pontine gigantocellular nucleus; TH: tyrosine hydroxylase.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Lavezzi, A.M.; Mehboob, R.; Piscioli, F.; Pusiol, T. New Step in Understanding the Pathogenetic Mechanism of Sudden Infant Death Syndrome: Involvement of the Pontine Reticular Gigantocellular Nucleus. Int. J. Mol. Sci. 2024, 25, 6920. https://doi.org/10.3390/ijms25136920

AMA Style

Lavezzi AM, Mehboob R, Piscioli F, Pusiol T. New Step in Understanding the Pathogenetic Mechanism of Sudden Infant Death Syndrome: Involvement of the Pontine Reticular Gigantocellular Nucleus. International Journal of Molecular Sciences. 2024; 25(13):6920. https://doi.org/10.3390/ijms25136920

Chicago/Turabian Style

Lavezzi, Anna Maria, Riffat Mehboob, Francesco Piscioli, and Teresa Pusiol. 2024. "New Step in Understanding the Pathogenetic Mechanism of Sudden Infant Death Syndrome: Involvement of the Pontine Reticular Gigantocellular Nucleus" International Journal of Molecular Sciences 25, no. 13: 6920. https://doi.org/10.3390/ijms25136920

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop